Association of killer cell immunoglobulin-like receptor polymorphisms with chronic hepatitis C and responses to therapy in Brazil

Genetics and Molecular Biology

Volumn 36, Issue 1, 2013, Pages 22-27

  de Vasconcelos, Janaina Mota ^a   Móia, Lizomar de Jesus Maués Pereira ^a,b   Amaral, Ivanete do Socorro Abraçado ^b   Miranda, Esther Castello Branco Mello ^a   CicaliseTakeshita, Louise Yukari ^a   de Oliveira, Layanna Freitas ^a   Mendes, Lilian de Araújo Melo ^a   Sastre, Danuta ^a   Tamegão Lopes, Bruna Pedroso ^a   Pedroza, Larysse Santa Rosa de Aquino ^a   dos Santos, Sidney Emanuel Batista ^a   Soares, Manoel do Carmo Pereira ^c   de Araújo, Marialva Tereza Ferreira ^a   Bandeira, Camila Lucas ^a   da Silva, Adriana Maria Paixão de Sousa ^a   de Medeiros, Zilene Lameira ^a   Sena, Leonardo ^a   Demachki, Samia ^a   dos Santos, Eduardo José Melo ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b UNIVERSIDADE DO ESTADO DO PARÁ   (Brazil)

^c INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

HCV; Hepatitis C; HLA C; KIR; KIR2DL2

Indexed keywords

ALANINE; INTERFERON; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; PEGINTERFERON; RIBAVIRIN;

ADULT; ARTICLE; BRAZIL; CHRONIC PATIENT; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HLA C ASP80 GENE; HOMOZYGOSITY; HUMAN; KIR2DL2 GENE; KIR2DL3 GENE; KIR2DS2 GENE; KIR2DS3 GENE; KIR2DS5 GENE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; TREATMENT RESPONSE;

EID: 84874836166     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ayres M, Salzano FM, Franco MHLP and Barros RMS (1976) The association of blood groups, ABH secretion, haptoglobins and hemoglobins with filariasis. Hum Hered 26:105-109.
2. Bode JG, Brenndörfer ED and Häussinger D (2008) Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response. Biol Chem 389:1283-1298
3. BRASIL, Ministério da Saúde (2011) Protocolo Clínico e Diretrizes Terapêuticas para Hepatite Viral C e Coinfecções. Série A. Normas e Manuais Técnicos. Secretaria de Vigilância em Saúde, Brasília, pp 1-84.
4. Carneiro VL, Lemaire DC, Bendicho MT, Souza SL, Cavalcante LN, Angelo AL, Freire SM, Mendes CM, Santana N, Lyra LG, et al. (2010) Natural killer cell receptor and HLA-C gene polymorphisms among patients with hepatitis C: A comparison between sustained virological responders and non-responders. Liver Int 30:567-573.
5. Dring MM, Morrison MH, McSharry BP, Guinan KJ, Hagan R, Irish HCV Research Consortium, O'Farrelly C and Gardiner CM (2011) Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection. Proc Natl Acad Sci USA 108:5736-5741.
6. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399-401.
7. Gonzalez-Galarza FF, Christmas S, Middleton D and Jones AR (2011) Allele frequency net: A database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 39:D913-D919.
8. Grünhage F and Nattermann J (2010) Viral hepatitis: Human genes that limit infection. Best Pract Res Clin Gastroenterol 24:709-723.
9. Guerreiro JF and Chautard-Freire-Maia EA (1988) ABO and blood groups, migration and estimates of racial admixture for the population of Belem, State of Para, Brazil. Rev Bras Genet 11:171-186.
10. Hong HA, Loubser AS, de Assis Rosa D, Naranbhai V, Carr W, Paximadis M, Lewis DA, Tiemessen CT and Gray CM (2011) Killer-cell immunoglobulin-like receptor genotyping and HLA killer-cell immunoglobulin-likereceptor-ligand identification by real-time polymerase chain reaction. Tissue Antigens 78:185-194.
11. Irshad M, Khushboo I and Singh S (2008) Hepatitis C Virus (HCV): A review of immunological aspects. Int Rev Immunol 27:497-517.
12. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, et al. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305:872-874.
13. Knapp S, Warshow U, Hegazy D, Brackenbury L, Guha IN, Fowell A, Little AM, Alexander GJ, Rosenberg WM, Cramp ME, et al. (2010) Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology 51:1168-1175.
14. Liu CH, Liu CJ, Lin CL, Liang CC, Hsu SJ, Yang SS, Hsu CS, Tseng TC, Wang CC, Lai MY, et al. (2008) Pegylated interferon-alpha-2a plus ribavirin for treatment-naïve Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial. Clin Infect Dis 47:1260-1269.
15. Marangon AV, Silva GF, de Moraes CF, Grotto RM, Pardini MI, de Pauli DS, Sell AM, Visentainer JE and Moliterno RA (2011) KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C. Hum Immunol 72:1074-1078.
16. Martin MP, Nelson G, Lee JH, Pellett F, Gao X, Wade J, Wilson MJ, Trowsdale J, Gladman D and Carrington M (2002) Cutting edge: Susceptibility to psoriatic arthritis: influence of activating Killer Ig-like Receptor genes in the absence of specific HLA-C Alleles 1. J Immunol 169:2818-2822.
17. Martins T, Narciso-Schiavon JL and Schiavon LL (2011) Epidemiologia da infecção pelo virus da hepatite C. Rev Assoc Med Bras 57:107-112.
18. Mello LA, Melo-Junior MR, Albuquerque ACC and Coelho MRCD (2007) Soroprevalência da hepatite C em pacientes hemodialisados. Rev Soc Bras Med Trop 40:290-294
19. Miranda EC, Moia L de J, Amaral Ido S, Barbosa MS, Conde SR, de Araújo MT, da Cruz Edo R, Demachki S, Bensabath G, Soares MC (2004) Hepatitis B and C virus infection and the hepatocellular carcinoma in the East Amazon, Brazil. Rev Soc Bras Med Trop 37:47-51.
20. Montes-Cano MA, Caro-Oleas JL, Romero-Gómez M, Diago M, Andrade R, Carmona I, Aguilar Reina J, Núñez-Roldán A and González-Escribano MF (2005) HLA-C and KIR genes in hepatitis C virus infection. Hum Immunol 66:1106-1109
21. Paladino N, Flores AC, Marcos CY, Fainboim H, Theiler G, Arruvito L, Williams F, Middleton D and Fainboim L (2007) Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus. Tissue Antigens 69:109-111
22. Paraná R, Vitvitsk L and Pereira JE (2008) Hepatotropic viruses in the Brazilian Amazon: A health threat. Braz J Infect Dis 12:253-256.
23. Parham P (2005) MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5:201-214.
24. Pedroza LS, Sauma MF, Vasconcelos JM, Takeshita LY, Ribeiro-Rodrigues EM, Sastre D, Barbosa CM, Chies JA, Veit TD, Lima CP, et al. (2011) Systemic lupus erythematosus: Association with KIR and SLC11A1 polymorphisms, ethnic predisposition and influence in clinical manifestations at on-set revealed by ancestry genetic markers in an urban Brazilian population. Lupus 20:265-273.
25. Romero V, Azocar J, Zúñiga J, Clavijo OP, Terreros D, Gu X, Husain Z, Chung, RT, Amos C and Yunis EJ (2008) Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in hepatitis c virus infection outcome. Mol Immunol 45:2429-2436.
26. Santos NP, Ribeiro-Rodrigues EM, Ribeiro-Dos-Santos AK, Pereira R, Gusmão L, Amorim A, Guerreiro JF, Zago MA, Matte C, Hutz MH, et al. (2010) Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel. Hum Mutat 31:184-190.
27. nd edition. Cold Spring Harbor Laboratory, Cold Spring Harbor.
28. Schneider H and Salzano FM (1979) Gm allotypes and racial admixture in two Brazilian populations. Hum Genet 53:101-105.
29. Sham PC and Curtis D (1995) Monte Carlo tests for associations between diseases and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
30. Single RM, Martin MP, Meyer D, Gao X and Carrington M (2008) Methods for assessing gene content diversity of KIR with examples from a global set of populations. Immunogenetics 60:711-725.
31. Vidal-Castiñeira JR, López-Vázquez A, Díaz-Peña R, Alonso-Arias R, Martínez-Borra J, Pérez R, Fernández-Suárez J, Melón S, Prieto J, Rodrigo L, et al. (2010) Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J Virol 84:475-481.
32. Vejbaesya S, Nonnoi Y, Tanwandee T and Srinak D (2011) Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a. J Med Virol 83:1733-1737.